BRK-B vs FSK
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
FSK presents a high-risk profile characterized by a stable but mediocre Piotroski F-Score of 4/9 and a severe disconnect between current price ($10.52) and its Graham Number ($4.34). While the Price-to-Book ratio of 0.50 suggests the stock is undervalued relative to assets, the fundamental deterioration is alarming, evidenced by a catastrophic 7000% dividend payout ratio and a -141.30% Q/Q revenue collapse. The combination of a 0/100 technical trend and zero earnings beats in the last four quarters indicates a strong bearish momentum that outweighs the low book valuation.
Compare Another Pair
Related Comparisons
BRK-B vs FSK: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and FS KKR Capital Corp. (FSK) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.